IMPROVEMENTS IN QUALITY OF LIFE IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

被引：0

作者：

Hatemi, Gulen ^{[1
]}

Mahr, Alfred ^{[2
]}

Takeno, Mitsuhiro ^{[3
]}

Kim, Doyoung ^{[4
]}

Melikoglu, Melike ^{[5
]}

Cheng, Sue ^{[6
]}

Mccue, Shannon ^{[6
]}

Paris, Maria ^{[6
]}

Chen, Mindy ^{[6
]}

Yazici, Yusuf ^{[7
]}

机构：

[1] Istanbul Univ Cerrahpasa, Med, Istanbul, Turkey

[2] St Louis Hosp, Paris, France

[3] Nippon Med Sch, Bunkyo Ku, Tokyo, Japan

[4] Yonsei Univ, Coll Med, Seoul, South Korea

[5] Istanbul Univ Cerrahpasa, Istanbul, Turkey

[6] Celgene Corp, Summit, NJ USA

[7] NYU, Sch Med, New York, NY USA

来源：

RHEUMATOLOGY | 2019年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

250

引用

页数：1

共 50 条

[21] Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial
Hamuryudan, V
Mat, C
Saip, S
Ozyazgan, Y
Siva, A
Yurdakul, S
Zwingenberger, K
Yazici, H
ANNALS OF INTERNAL MEDICINE, 1998, 128 (06) : 443 - +
[22] Dietary supplementation and quality of life of older patients: A randomized, double-blind, placebo-controlled trial
Gariballa, Salah
Forster, Sarah
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (12) : 2030 - 2034
[23] Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study
Uchimura, Naohisa
Taniguchi, Mitsutaka
Ariyoshi, Yu
Oka, Yasunori
Togo, Osamu
Uchiyama, Makoto
SLEEP MEDICINE, 2024, 122 : 27 - 34
[24] Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study
Motoya, Satoshi
Watanabe, Kenji
Ogata, Haruhiko
Kanai, Takanori
Matsui, Toshiyuki
Suzuki, Yasuo
Shikamura, Mitsuhiro
Sugiura, Kenkichi
Oda, Kazunori
Hori, Tetsuharu
Araki, Takahiro
Watanabe, Mamoru
Hibi, Toshifumi
PLOS ONE, 2019, 14 (02):
[25] Two randomized, double-blind, placebo-controlled phase 3 trials of linaclotide in adults with irritable bowel syndrome: effects on quality of life
Carson, R.
Tourkodimitris, S.
Lewis, B. E.
Johnston, J. M.
NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 : 29 - 29
[26] QUALITY OF LIFE OUTCOMES IN RAISE: A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ZILUCOPLAN IN GMG
Weiss, Michael D.
Genge, Angela
Hussain, Yessar
Kaminski, Henry J.
Leite, M. Isabel
Mantegazza, Renato
Utsugisawa, Kimiaki
Vu, Tuan
Brock, Melissa
Boroojerdi, Babak
Vanderkelen, Mark
de la Borderie, Guillemette
Duda, Petra W.
Howard, James F., Jr.
MUSCLE & NERVE, 2022, 66 : S137 - S137
[27] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
Taslimi, Shervin
Vahidi, Hamed
Pourvaziri, Ali
Modabbernia, Amirhossein
Fallah, Arezoo Yeke
Yazdani, Nasrin
Taslimi, Negin
Hosseini, Mostafa
Zarandi, Masoud Motesadi
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (05) : 1635 - 1641
[28] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
Shervin Taslimi
Hamed Vahidi
Ali Pourvaziri
Amirhossein Modabbernia
Arezoo Yeke Fallah
Nasrin Yazdani
Negin Taslimi
Mostafa Hosseini
Masoud Motesadi Zarandi
European Archives of Oto-Rhino-Laryngology, 2013, 270 : 1635 - 1641
[29] Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study
Keary, Christopher
Bird, Lynne M.
de Wit, Marie-Claire
Hatti, Shivkumar
Heimer, Gali
Heussler, Helen
Kolevzon, Alexander
Mathews, Adera
Ochoa-Lubinoff, Cesar
Tan, Wen-Hann
Yan, Ying
Adams, Maxwell
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 47 : 6 - 12
[30] Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
Genovese, Mark C.
Jarosova, Katerina
Cieslak, Dorota
Alper, Jeffrey
Kivitz, Alan
Hough, Douglas R.
Maes, Peter
Pineda, Lilia
Chen, Mindy
Zaidi, Farrukh
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) : 1703 - 1710

← 1 2 3 4 5 →